Clinical trial
Study Evaluating Streptococcus Pneumoniae Nasopharyngeal Carriage Rate in…
NCT00488371 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00488371 |
|---|---|
| Title | Study Evaluating Streptococcus Pneumoniae Nasopharyngeal Carriage Rate in Children Receiving Prevnar® |
| Official title | Evaluation of Streptococcus Pneumoniae Nasopharyngeal Carriage Rate in Children Receiving Pneumococcal Conjugated Vaccine (Prevnar®) Under the Auspices of the Taipei City Government Vaccination Program |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Pneumococcal Infections |
| Intervention type | Biological |
| Interventions | Pneumococcal Conjugated Vaccine (Prevnar®) |
| Enrollment | 250 |
| Start date | Nov 1, 2006 |
| Completion | Apr 1, 2007 |
| First posted | Jun 20, 2007 |
| Last update posted | Dec 20, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: